Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1635

1.

Activity of echinocandins and triazoles against a contemporary (2012) worldwide collection of yeast and moulds collected from invasive infections.

Castanheira M, Messer SA, Jones RN, Farrell DJ, Pfaller MA.

Int J Antimicrob Agents. 2014 Jul 23. pii: S0924-8579(14)00202-7. doi: 10.1016/j.ijantimicag.2014.06.007. [Epub ahead of print]

PMID:
25129315
[PubMed - as supplied by publisher]
2.

Ceftazidime-avibactam and comparator agents tested against urinary tract isolates from a global surveillance program (2011).

Flamm RK, Sader HS, Farrell DJ, Jones RN.

Diagn Microbiol Infect Dis. 2014 Jul 24. pii: S0732-8893(14)00287-9. doi: 10.1016/j.diagmicrobio.2014.07.005. [Epub ahead of print]

PMID:
25128477
[PubMed - as supplied by publisher]
3.

Acute Changes in Sleep Duration on Eating Behaviors and Appetite-Regulating Hormones in Overweight/Obese Adults.

Hart CN, Carskadon MA, Demos KE, Van Reen E, Sharkey KM, Raynor HA, Considine RV, Jones RN, Wing RR.

Behav Sleep Med. 2014 Aug 8:1-13. [Epub ahead of print]

PMID:
25105727
[PubMed - as supplied by publisher]
4.

Relationship between Ceftolozane/Tazobactam Exposure and Selection for Pseudomonas aeruginosa Resistance in a Hollow-Fiber Infection Model.

VanScoy B, Mendes RE, Castanheira M, McCauley J, Bhavnani SM, Jones RN, Friedrich L, Steenbergen J, Ambrose PG.

Antimicrob Agents Chemother. 2014 Jul 28. pii: AAC.02310-13. [Epub ahead of print]

PMID:
25070105
[PubMed - as supplied by publisher]
5.

Reply: regional pooling of national data from a small number of sites can be misleading: maybe yes? But data can be complimentary to other studies and valuable to infectious disease physicians!

Jones RN, Mendes RE, Castanheira M.

Diagn Microbiol Infect Dis. 2014 Jun 13. pii: S0732-8893(14)00195-3. doi: 10.1016/j.diagmicrobio.2014.05.003. [Epub ahead of print] No abstract available.

PMID:
25064002
[PubMed - as supplied by publisher]
6.

Psychiatric and Self-Injury Profiles of Adolescent Suicide Attempters versus Adolescents Engaged in Nonsuicidal Self-Injury.

Kim KL, Galvan T, Puzia ME, Cushman GK, Seymour KE, Vanmali R, Jones RN, Spirito A, Dickstein DP.

Suicide Life Threat Behav. 2014 Jul 24. doi: 10.1111/sltb.12110. [Epub ahead of print]

PMID:
25060743
[PubMed - as supplied by publisher]
7.

Development of the Primary Care Quality-Homeless (PCQ-H) instrument: a practical survey of homeless patients' experiences in primary care.

Kertesz SG, Pollio DE, Jones RN, Steward J, Stringfellow EJ, Gordon AJ, Johnson NK, Kim TA, Daigle SG, Austin EL, Young AS, Chrystal JG, Davis LL, Roth DL, Holt CL.

Med Care. 2014 Aug;52(8):734-42. doi: 10.1097/MLR.0000000000000160.

PMID:
25023918
[PubMed - in process]
8.

Revised Reference Broth Microdilution Method for Testing Telavancin: Effect on MIC Results and Correlation with Other Testing Methodologies.

Farrell DJ, Mendes RE, Rhomberg PR, Jones RN.

Antimicrob Agents Chemother. 2014 Sep;58(9):5547-51. doi: 10.1128/AAC.03172-14. Epub 2014 Jul 14.

PMID:
25022579
[PubMed - in process]
Free Article
9.

Serotype distribution and antimicrobial susceptibility of USA Streptococcus pneumoniae isolates collected prior to and post introduction of 13-valent pneumococcal conjugate vaccine.

Mendes RE, Costello AJ, Jacobs MR, Biek D, Critchley IA, Jones RN.

Diagn Microbiol Infect Dis. 2014 May 24. pii: S0732-8893(14)00214-4. doi: 10.1016/j.diagmicrobio.2014.05.020. [Epub ahead of print]

PMID:
24974272
[PubMed - as supplied by publisher]
10.

Isavuconazole and nine comparator antifungal susceptibility profiles for common and uncommon Candida species collected in 2012: application of new CLSI clinical breakpoints and epidemiological cutoff values.

Castanheira M, Messer SA, Rhomberg PR, Dietrich RR, Jones RN, Pfaller MA.

Mycopathologia. 2014 Aug;178(1-2):1-9. doi: 10.1007/s11046-014-9772-2. Epub 2014 Jun 21.

PMID:
24952015
[PubMed - in process]
11.

Use of Anidulafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 4,290 Clinical Isolates of Candida by Using CLSI Methods and Interpretive Criteria.

Pfaller MA, Diekema DJ, Jones RN, Castanheira M.

J Clin Microbiol. 2014 Sep;52(9):3223-9. doi: 10.1128/JCM.00782-14. Epub 2014 Jun 20.

PMID:
24951808
[PubMed - in process]
12.

Quality Control MIC Ranges Used for Telavancin with Application of a Revised CLSI Reference Broth Microdilution Method.

Ross JE, Mendes RE, Jones RN.

J Clin Microbiol. 2014 Sep;52(9):3399-401. doi: 10.1128/JCM.01210-14. Epub 2014 Jun 11.

PMID:
24920777
[PubMed - in process]
Free Article
13.

Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011-12).

Sader HS, Farrell DJ, Castanheira M, Flamm RK, Jones RN.

J Antimicrob Chemother. 2014 Jun 10. pii: dku184. [Epub ahead of print]

PMID:
24917579
[PubMed - as supplied by publisher]
14.

Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms.

Mendes RE, Deshpande LM, Jones RN.

Drug Resist Updat. 2014 Apr;17(1-2):1-12. doi: 10.1016/j.drup.2014.04.002. Epub 2014 Apr 6.

PMID:
24880801
[PubMed - in process]
15.

Decreased Ceftriaxone Susceptibility in Emerging (35B and 6C) and Persisting (19A) Streptococcus pneumoniae Serotypes in the United States, 2011-2012: Ceftaroline Remains Active In Vitro among ╬▓-Lactam Agents.

Mendes RE, Biek D, Critchley IA, Farrell DJ, Sader HS, Jones RN.

Antimicrob Agents Chemother. 2014 Aug;58(8):4923-7. doi: 10.1128/AAC.02976-14. Epub 2014 May 27.

PMID:
24867974
[PubMed - in process]
16.

Regional data analysis of Candida non-albicans strains collected in United States medical sites over a 6-year period, 2006-2011.

Pfaller MA, Jones RN, Castanheira M.

Mycoses. 2014 May 26. doi: 10.1111/myc.12206. [Epub ahead of print]

PMID:
24863164
[PubMed - as supplied by publisher]
17.

Ceftolozane/tazobactam activity tested against Gram-negative bacterial isolates from hospitalised patients with pneumonia in US and European medical centres (2012).

Farrell DJ, Sader HS, Flamm RK, Jones RN.

Int J Antimicrob Agents. 2014 Jun;43(6):533-9. doi: 10.1016/j.ijantimicag.2014.01.032. Epub 2014 Mar 26.

PMID:
24856078
[PubMed - in process]
18.

Quantifying the matrix of relationships between reduced vancomycin susceptibility phenotypes and outcomes among patients with MRSA bloodstream infections treated with vancomycin .

Lodise TP, Drusano GL, Lazariu V, El-Fawal N, Evans A, Graffunder E, Stellrecht K, Mendes RE, Jones RN, Cosler L, McNutt LA.

J Antimicrob Chemother. 2014 Sep;69(9):2547-55. doi: 10.1093/jac/dku135. Epub 2014 May 19.

PMID:
24840624
[PubMed - in process]
19.

Pain characteristics associated with the onset of disability in older adults: the maintenance of balance, independent living, intellect, and zest in the Elderly Boston Study.

Eggermont LH, Leveille SG, Shi L, Kiely DK, Shmerling RH, Jones RN, Guralnik JM, Bean JF.

J Am Geriatr Soc. 2014 Jun;62(6):1007-16. doi: 10.1111/jgs.12848. Epub 2014 May 13.

PMID:
24823985
[PubMed - indexed for MEDLINE]
20.

Ceftolozane/tazobactam activity tested against aerobic Gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012).

Sader HS, Farrell DJ, Flamm RK, Jones RN.

J Infect. 2014 Sep;69(3):266-77. doi: 10.1016/j.jinf.2014.04.004. Epub 2014 Apr 26.

PMID:
24780763
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk